Red Cell Immunization in Multiply Transfused Thalassaemic Paediatric Patients- A Preliminary Study
DOI:
https://doi.org/10.3329/bjms.v25i1.86413Keywords:
Red cell immunization; Alloantibodies; Autoantibodies; Thalassaemia; Multiple transfusionsAbstract
Background Multiply transfused thalassaemia patients can develop red cell immunization that can potentially cause haemolytic transfusion reactions and pose problems with compatibility testing for future transfusions. Previous research on red cell immunization in transfusion-dependent thalassaemia patients has not focused on paediatric groups. Objective This study aims to evaluate the prevalence of red cell immunization in transfusion dependent paediatric thalassaemia patients and identify its potential risk factors. Methods Clinical and serological data of transfusion-dependent thalassaemia patients aged 18 years and below were collected retrospectively from the Hospital Laboratory Information System. Results of antibody identification of the alloantibody and/or autoantibody were collected and analysed. Results Of the 32 patients included in our study, 17(53.1%), (11)34.4%, (2)6.3%, (2)6.3%, patients had HbE/β thalassaemia, β-thalassaemia major, alpha thalassaemia, thalassaemia intermedia/homozygous delta beta thalassaemia respectively. Out of 32 patients, five have developed antibodies against RBC antigens, giving rise to the prevalence of red cell immunization at 15.6%, in which 12.5% were alloantibodies and 3.1% were autoantibodies. The alloantibodies detected were anti E, anti-e, anti-c and alloantibody against lowfrequency antigen with an unknown specificity. The autoantibodies were nonspecific autoIgG. No significant association was observed between antibody formation and risk factors such as diagnosis, gender, blood group, age at first transfusion and number of packed cells transfused. Conclusion This study has successfully answered the prevalence of red cell immunization in multiply transfused paediatric thalassaemia. Our data showed prevalence of red cell immunization at 15.6%, in which 12.5% were alloantibodies and 3.1% were autoantibodies. We acknowledged that a bigger sample size with an extended study period is required.
BJMS, Vol. 25 No. 01 January’26 Page : 143-149
Downloads
29
21
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Suria Abdul Aziz, Rabeya Yousuf, Ahmad Hafiz Azman, Nur‘Alia Sufia Amran, Nur Farzana Abdullah Pirus, Jeniffer Peter, Siti Rohana Abdul Rahman, Zaleha Md Isa, Nurasyikin Yusof, C-Khai Loh

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.